Join PATH at the International Papillomavirus conference in Seattle

August 21, 2014 by PATH

PATH will highlight our work to leverage new approaches and tools in the fight against cervical cancer at the 29th International Papillomavirus Conference and Clinical & Public Health Workshops, August 20—25, 2014, at the Washington State Convention Center in downtown Seattle.

During the conference, PATH staff will participate in the following events, focused on cervical cancer prevention in low-resource settings:

Wednesday, August 20

  • Session PC-PH1 (Public Health): "Vaccines–Experience to Date in GAVI and Non-GAVI Settings." Scott LaMontagne, senior program officer, Vaccine Access and Delivery at PATH, will chair this session. Other speakers include Lauri Markowitz of US Centers for Disease Control and Prevention and Susan Wang of the World Health Organization (WHO). 9:00—10:15 a.m., Ballroom 6C.
  • Session PC-PH2 (Public Health): "Vaccines–Interactive Session Focused on Implementation of Future Developments." Scott LaMontagne is a roundtable facilitator for this session, which is chaired by Gena Ogilvie of the British Colombia Center for Disease Control, Canada. 10:45 a.m.—12:15 p.m., Ballroom 6C.
  • Session PC-PH4 (Public Health): Service Integration. José Jéronimo, senior advisor for women's cancers at PATH, will speak on "Integration of Cervical Cancer Screening With Primary Health Care: Strategies in Central America." The session will be chaired by Mona Saraiya of US Centers for Disease Control and Prevention. Other speakers include Susan Holland of Marie Stopes International and Megan Huchko of University of California San Francisco. 3:30—5:00 p.m., Ballroom 6C.

Thursday, August 21

  • Session PC-C5 (Clinical Sciences): Treatment. José Jéronimo will speak on "Existing and Upcoming Treatments for Cervical Precancer." The session will be chaired by Juan Felix of the University of Southern Carolina. Other panel speakers include Ricky Lu of Jhpiego. 9:00—10:15 a.m., Ballroom 6A.
  • Session PC-PH6 (Public Health): Screening in Settings with Different Resource Levels. Vivien Tsu will speak on "Appropriate Cervical Screening and Precancer Treatment Programs for Low-Resource Settings: Options and Trade-offs." The session will be chaired by Guy Stallworthy, formerly of the Bill & Melinda Gates Foundation. Other speakers include Dorota Gertig of Victorian Cytology Services, Australia, and Catterina Ferreccio of Pontificia Universidad Católica, Chile. 10:45 a.m.—12:45 p.m., Ballroom 6C.
  • Session PC-PH7 (Public Health): Online Resources. Scott Wittet, lead for advocacy and communication on cervical cancer prevention at PATH, will present PATH's online cervical cancer prevention planner, the RHO Cervical Cancer Library, and will discuss the Cervical Cancer Action coalition (which PATH cochairs with the American Cancer Society) and its tools. This workshop is chaired by Stephen Schwartz of Fred Hutchinson Cancer Research Center. Other speakers include Moshen Naghavi of Institute for Health Metrics and Evaluation and Silvia de Sanjose of Catalan Institute of Oncology, Spain. 1:45—3:00 p.m., Ballroom 6C.
  • Opening Plenary: Accelerating Innovation: A Model for 21st Century Leadership. Steve Davis, president and chief executive officer of PATH, will speak about how tackling the globe's most challenging imperatives will demand that more innovations reach scale in the developing world. 5:00—6:30 p.m., Benaroya Hall, 200 University St.

Friday, August 22

  • Satellite Symposium 01: Alternate Dosing of the HPV Vaccine. Scott LaMontagne will speak on "Implementation of Alternative Dosing Programs for the HPV Vaccine Program in the Global Setting: Current Status, Lessons Learned, and Future Priorities" as part of a panel discussion. 7:30—8:30 a.m., Hall 4B, Breakout room 1.
  • Poster Session 1 and Poster Discussions. Francesca Holme, program officer for women's cancers at PATH, will present the poster "Challenges in Introducing HPV DNA Testing in Latin America: Moving Beyond Cost-Effectiveness." 3:15—5:15 p.m., Hall 4B.

Saturday, August 23

  • Satellite Symposium 05: Incomplete Vaccination Among Target Age Adolescents: Need for Completing Series? Scott LaMontagne will speak on "Country Experience with Two-Dose Schedules for HPV Vaccine" as part of a panel discussion. 7:30—8:30 a.m., Hall 4B, Breakout room 2.
  • Poster Session 2 and Poster Discussions. Cathy Ndiaye, senior program officer, Reproductive Health, PATH, will present the poster "HPV DNA, mRNA, and p16INK4a Detection in Head and Neck Cancer: A Systematic Review and Meta-analysis." 1:45—3:45 p.m., Hall 4B.

Sunday, August 24

  • Poster Session 3 and Poster Discussions. Cathy Ndiaye will present the poster "Risk of High-Grade Squamous Intra-epithelial Lesions in Older Women Newly Infected by High-Risk Human Papillomaviruses." 10:15 a.m.—12:15 p.m., Hall 4B.
  • Session PH.OA06: Economics and Mathematical Modeling. Vivien Tsu will present an abstract (co-authored with Mercy Mvundura, PATH health economist) on "Scaling up Cervical Cancer Screening in Africa: What Would It Cost?" This session will be chaired by Karen Canfell of University of New South Wales, Australia, and Jane Kim of Harvard University. 3:45—5:45 p.m., Ballroom 6C.

Monday, August 25

  • Satellite Symposium 08: Update on HPV Vaccine Introductions in Developing Countries: Progress to Date and Lessons Learned. Scott LaMontagne will speak on possible implementation challenges identified prior to HPV vaccine availability. Representatives from GAVI and WHO will speak on whether these possible challenges ever occurred and if so, how countries responded. 7:30—8:30 a.m., Ballroom 6A.
  • Session PH.OA07: Screening. Jacqueline Sherris, former vice president for Public Health Impact at PATH, will present an abstract (coauthored with Vivien Tsu and José Jéronimo) that reflects on 20 years of effort to reduce cervical cancer burden worldwide. This session will be chaired by Mark Arbyn of Scientific Institute of Health, Belgium, and Mona Saraiya of US Centers for Disease Control and Prevention. 8:45—10:15 a.m., Ballroom 6C.

More information